$ARWR

$59.03 +$0.00 (0.0%) After hours

$ARWR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$ARWR Management Team

Mr. James Hamilton

Chief Medical Officer

Head - Research and Development

Age 48

Compensation $2.966M USD

Sex Male

Mr. Vincent Anzalone

Investor Relations

Age -

Compensation -

Sex Male

Dr. Christopher Anzalone

Chairman of the Board

President

Chief Executive Officer

Age 56

Compensation $9.030M USD

Sex Male

Mr. Daniel Apel

Chief Financial Officer

Age 60

Compensation $1.955M USD

Sex Male

Mr. Patrick O'Brien

Chief Operating Officer

Company Secretary

Age 62

Compensation $3.030M USD

Sex Male

Name / Title	Age	Compensation	Sex
Mr. James Hamilton Chief Medical Officer Head - Research and Development	48	$2.966M USD	Male
Mr. Vincent Anzalone Investor Relations	-	-	Male
Dr. Christopher Anzalone Chairman of the Board President Chief Executive Officer	56	$9.030M USD	Male
Mr. Daniel Apel Chief Financial Officer	60	$1.955M USD	Male
Mr. Patrick O'Brien Chief Operating Officer Company Secretary	62	$3.030M USD	Male

Board of Directors

From the proxy statement filed Jan 27, 2026

Directors

serving now

Independent

6 of 6

stated in the proxy; 1 not stated

Average tenure

10.0 years

from year joined

CEO also chairs the board

Yes

Christopher Anzalone

Director	Age	On board	Independent	Committees	Other public boards	Pay
Christopher Anzalone CEO, Board chair	56	2007 19 years	Not stated	None stated	None stated	Paid as CEO
Mauro Ferrari	66	2010 16 years	Independent	Science Committee · Chair Audit Committee Nomination Committee	None stated	Not stated
Hongbo Lu	55	2024 2 years	Independent	Science Committee Nomination Committee Compensation Committee	Terns Pharmaceuticals, Inc., Zenas Biopharma Inc	Not stated
Adeoye Olukotun	81	2020 6 years	Independent	Science Committee · Chair Nomination Committee	Tonix Pharmaceuticals Holding Corp.	Not stated
Michael S. Perry	66	2011 15 years	Independent	Compensation Committee · Chair Audit Committee Nomination Committee Science Committee	None stated	Not stated
Victoria Vakiener	62	2022 4 years	Independent	Nomination Committee · Chair Audit Committee	None stated	Not stated
William Waddill Lead independent director	68	2018 8 years	Independent	Audit Committee · Chair Compensation Committee Nomination Committee	Protagonist Therapeutics, Inc., Annexon, Inc.	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

3 disclosed in the proxy filed Jan 27, 2026

Dr. Bruce Given

brother of Dr. Douglass Given, the Company's former Director and Chairman of the Board

$280,000

since August 1, 2025

Consulting arrangement with the Company at a yearly fee, beginning August 1, 2025

Open in proxy

Dr. Bruce Given

brother of Dr. Douglass Given, the Company's former Director and Chairman of the Board

$887,227

fiscal year 2025

Base salary, bonus and consulting fees earned, plus 100,000 RSUs awarded in fiscal 2025

Open in proxy

Vincent Anzalone

brother of Christopher Anzalone, the Company's Chief Executive Officer, President, Director and Board Chair

$417,568

fiscal year 2025

Employment as Senior Vice President, Investor Relations and Corporate Communications, including base salary, bonus and stock awards

Open in proxy

Comments

Company Executives

$ARWR Management Team

Mr. James Hamilton

Mr. Vincent Anzalone

Dr. Christopher Anzalone

Mr. Daniel Apel

Mr. Patrick O'Brien

Board of Directors

Related-party transactions